IOTOD 2012 used a variety of interactive formats to bring the latest data on the treatment of opioid dependence to life.
Case studies, audience participation, panel discussions, a complex case clinic and an international clinicans’ manifesto were just some of the methods used to engage delegates in applying the evolving evidence base to improving treatment outcomes. Topics ranged from co-dependencies and complex patients to emerging issues such as gender effects.
Chairs
Professor Sharon Walsh
Professor of Behavioral Science and Psychiatry Center on Drug and Alcohol Research, University of Kentucky
Lexington, KY, USA
Speakers
Dr Steven Passik
Memorial Sloan Kettering Cancer Center
New York, USA
Professor Markus Heilig
Clinical Director, National Institute on Alcohol Abuse and Alcoholism
Bethesda, Maryland, USA
Professor Ambros Uchtenhagen
President, Research Institute for Public Health and Addiction, Zurich University
Zurich, Switzerland
Professor Peter Hajek
Director, Tobacco Dependence Research Unit, Wolfson Institute of Preventative Medicine, Barts and the London School of Medicine and Dentistry
UK
Dr Susan Clarke
Consultant in Infectious Diseases, GUIDE Clinic, St James’s Hospital
Dublin, Ireland
Professor Elinore McCance-Katz
Professor of Psychiatry, University of California San Francisco
USA
Marc Auriacombe
Professor of Psychiatry and Addiction Medicine, University of Bordeaux
Bordeaux, France
Professor Seddon Savage
Director, Dartmouth Center on Addiction Recovery and Education
New Hampshire, USA
Dr Jenny Bearn
Consultant Psychiatrist/Honorary Senior Lecturer, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King’s College London
London, UK
